Search Results for " Asciminib "
Asciminib Related Products
Asciminib is a medication used in the treatment of chronic myelogenous leukemia (CML), a type of cancer that affects the blood and bone marrow. Specifically, asciminib is a tyrosine kinase inhibitor (TKI) that targets the ABL1 kinase protein.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Asciminib, pharmacopeial and non-pharmacopeial Asciminib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Asciminib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Asciminib-related products are thoroughly characterized. Asciminib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.